Link Explored for NSAID Use, Hormonal Contraception, VTE Risk
MONDAY, Sept. 11, 2023 (HealthDay News) — In women of reproductive age, nonsteroidal anti-inflammatory drug (NSAID) use is associated with venous thromboembolism, with significantly more additional events with concomitant use of high-/medium- versus …
Learn MoreHypertension, Anemia Contribute to Racial Disparities in Severe Maternal Morbidity
FRIDAY, Sept. 8, 2023 (HealthDay News) — Hypertension and anemia contribute to racial disparities in severe maternal morbidity (SMM), according to two studies published online Sept. 7 in Obstetrics & Gynecology.Stephanie A. Leonard, Ph.D., from Stanf…
Learn MorePulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
FRIDAY, Sept. 8, 2023 (HealthDay News) — Mortality related to pulmonary embolism (PE) has remained unchanged since 2006 and is higher among men, Black patients, and those living in rural areas, according to a study published online Aug. 8 in the Anna…
Learn MoreCombo of Certain Birth Control Pills, Painkillers Could Raise Women’s Clot Risk
FRIDAY, Sept. 8, 2023 (HealthDay News) — It’s well known that certain forms of birth control carry a small risk of blood clots. Now a large new study suggests that some common painkillers can magnify that risk.The study, of 2 million Danish women, fo…
Learn MoreKeeping Blood Pressure Under Control May Be Tougher in Colder Weather
FRIDAY, Sept. 8, 2023 (HealthDay News) — Winter months can be a challenge for those trying to keep their high blood pressure in check, new research suggests.In an analysis of more than 60,000 American adults being treated for high blood pressure at s…
Learn MorePreeclampsia: What It Is, Symptoms, Risk Factors, Treatment & Prevention
Preeclampsia is a health condition that can occur during and immediately after pregnancy.Learn what preeclampsia is, its symptoms, risk factors, causes, treatments and prevention strategies. Plus, find out how it affects your fetus and you during preg…
Learn MoreDOACs Reduce Dementia Risk Versus Warfarin in A-Fib
THURSDAY, Sept. 7, 2023 (HealthDay News) — For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk compared with warfarin, according to a systematic review and meta-analysis…
Learn MoreDOACs Reduce Dementia Risk Versus Warfarin in A-Fib
THURSDAY, Sept. 7, 2023 (HealthDay News) — For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk compared with warfarin, according to a systematic review and meta-analysis…
Learn MoreApixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
TUESDAY, Sept. 5, 2023 (HealthDay News) — Apixaban has a lower bleeding risk than warfarin or rivaroxaban during initial treatment for patients with venous thromboembolism (VTE), according to a study published online Aug. 28 in the Journal of Interna…
Learn MoreCélulas madre modificadas genéticamente ofrecen esperanza contra la anemia de células falciformes
VIERNES, 1 de septiembre de 2023 (HealthDay News) — Un tipo de terapia génica que edita con precisión una parte clave del ADN podría ofrecer una nueva forma de tratar la anemia de células falciformes, una dolorosa condición hereditaria que afecta pr…
Learn More